0

Dofequidar fumarate

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP158681493
CAS158681-49-3
Structure
Molecular Weight655.69
Description≥98% (HPLC)
SolubilityDMSO: 20 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

Dofequidar Fumarate (MS-209) in Combination With Cyclophosphamide, Doxorubicin, and Fluorouracil for Patients With Advanced or Recurrent Breast Cancer

Toshiaki Saeki, Tadashi Nomizu, Masakazu Toi, Yoshinori Ito, Shinzaburo Noguchi, Tadashi Kobayashi, Taro Asaga, Hironobu Minami, Naohito Yamamoto, Kenjiro Aogi, Tadashi Ikeda, Yasuo Ohashi, Wakao Sato, etc.

J Clin Oncol. 2007 Feb 1;25(4):411-7.

PMID: 17179098

1

Dofequidar Fumarate Sensitizes Cancer Stem-Like Side Population Cells to Chemotherapeutic Drugs by Inhibiting ABCG2/BCRP-mediated Drug Export

Ryohei Katayama, Sumie Koike, Shigeo Sato, Yoshikazu Sugimoto, Takashi Tsuruo, Naoya Fujita

Cancer Sci. 2009 Nov;100(11):2060-8.

PMID: 19673889

1

Drug Resistance in Chemotherapy for Breast Cancer

Toshiaki Saeki, Takashi Tsuruo, Wakao Sato, Kiyoshiro Nishikawsa

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:84-9.

PMID: 16273361

1

Gateways to Clinical Trials

M Bayes, X Rabasseda, J R Prous

Methods Find Exp Clin Pharmacol. 2002 Apr;24(3):159-84.

PMID: 12087878

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode